FUCHS
Clinical trials for FUCHS explained in plain language.
Never miss a new study
Get alerted when new FUCHS trials appear
Sign up with your email to follow new studies for FUCHS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Eye drops could make fuchs surgery less invasive
Disease control Recruiting nowThis study compares two surgical approaches for Fuchs endothelial dystrophy, a condition that clouds the cornea. One is a full corneal transplant (DMEK), the other is a simpler procedure that removes only the diseased cells (DSO) plus Ripasudil eye drops to help healing. 60 parti…
Matched conditions: FUCHS
Phase: PHASE3 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New eye drops aim to improve corneal transplant outcomes in fuchs dystrophy
Disease control Recruiting nowThis study tests an experimental eye drop called DT-168 in people with Fuchs endothelial corneal dystrophy who are already scheduled for a corneal transplant. The goal is to see if the drops are safe and affect disease-related markers. About 28 adults aged 30 and older with a spe…
Matched conditions: FUCHS
Phase: PHASE2 • Sponsor: Design Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC